Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07073209 · ClinicalTrials.gov registry record · NA

PENG vs Femoral Block for Hip Fracture Analgesia

A NA study of Hip Fractures, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
352
Enrollment target
1
Study location

NCT07073209: Recruiting NA study of Hip Fractures, sponsored by Weill Medical College of Cornell University.

NCT07073209 is a NA study of Hip Fractures that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 352 participants, below the 598-participant average among 15 other Hip Fractures trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07073209, a NA study of Hip Fractures, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
352 participants
Enrollment target
1
Study location

Study Summary

This study aims to compare the Pericapsular Nerve Group (PENG) block with femoral block for hip fracture pain. Participants presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block will receive either a PENG or femoral block. The choice of block will be dictated by a randomized monthly schedule, and all participants presenting during each four-week period will receive the designated block. A sub-group analysis will be performed to determine any difference in efficacy in participants with intracapsular versus extracapsular fractures.

Primary Outcome

The Numerical Rating Scale (NRS) measures the intensity of pain a subject experiences. where subjects rate their pain on a scale from zero to ten and each number corresponds to a different level of intensity. The lowest score 0 represents no pain and the highest score 10 represents the most intense feeling of pain.

Conditions Studied

Interventions

  • PROCEDURE PENG Block Administration
  • PROCEDURE Femoral Block Administration
  • DRUG Bupivacaine , epinephrine Dexamethasone

Study Locations (1)

New York

  • Weill Cornell Medicine - Manhattan

Trial Details

FieldValue
Enrollment Target 352 participants
Start Date 2025-07-10
Est. Completion 2027-04
Phase NA

What NCT07073209 shows while recruiting

NCT07073209 is an interventional study that assigns participants to a tested intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, below the 598-participant average among 15 other Hip Fractures trials with a reported enrollment target (41% lower).

The record links to 1 condition, with Hip Fractures appearing as the primary indexed condition, and to 3 interventions - of which PENG Block Administration is the first listed.

NCT07073209 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07073209 about?

NCT07073209 is a clinical study titled "PENG vs Femoral Block for Hip Fracture Analgesia". This study aims to compare the Pericapsular Nerve Group (PENG) block with femoral block for hip fracture pain. Participants presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block will receive either a PENG or femoral block. The choice of block will be dictated ...

What is the current status of trial NCT07073209?

This trial is currently recruiting. It is a NA study. The enrollment target is 352 participants. The study started on 2025-07-10. Estimated completion is 2027-04.

What conditions does trial NCT07073209 study?

This clinical trial studies the following conditions: Hip Fractures.

What interventions are being tested in trial NCT07073209?

The interventions under investigation include: PENG Block Administration (PROCEDURE), Femoral Block Administration (PROCEDURE), Bupivacaine , epinephrine Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT07073209?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07073209 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07073209's enrollment target sits among peer trials

352 7th of 15 higher than 9 of 15 other Hip Fractures trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hip Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05811936 · 352 participants · NA

    The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

  • NCT06258941 · 352 participants · Phase 1

    Classroom Break, Cognition, and Fitness in Elementary School Children

  • NCT06269081 · 352 participants · NA

    Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV

  • NCT06337292 · 352 participants · Phase 3

    Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07073209, the US trial registry maintained by the National Library of Medicine. NCT07073209 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.